Qingdao Inspur Health Technology Co., Ltd. Announcement on Obtaining the Commitment Letter for Special Loan for Stock Repurchase from Financial Institutions

MaticHoleFiller · 2026-03-28T08:47:50+00:00

Qingdao Inspur Health Technology Co., Ltd. approved the repurchase of some A-shares through the board of directors in March 2026. The total repurchase amount ranges from 56 million to 112 million yuan, and a stock repurchase loan commitment letter was obtained from China Everbright Bank Qingdao Branch. The loan amount does not exceed 100 million yuan and is exclusively used for stock repurchase.

MaticHoleFiller

2026-03-28 08:47:50

Abstract generation in progress

The company and all members of the board guarantee that the content of the information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.

Basic Information on Share Repurchase

Qingdao Yingpais Health Technology Co., Ltd. (hereinafter referred to as “the Company”) held the second meeting of the fourth board of directors on March 13, 2026, and reviewed and approved the proposal on the repurchase of the Company’s shares. The Company agreed to use its own funds and self-raised funds to repurchase part of the ordinary shares (A shares) issued by the Company through centralized bidding. The repurchased shares will be used for implementing equity incentives and/or employee stock ownership plans. The repurchase price will not exceed (including) RMB 47.86 per share, and the upper limit of the repurchase price does not exceed 150% of the average trading price of the Company’s shares over the 30 trading days prior to the board’s approval of the repurchase plan. The total amount of repurchase funds will not be less than RMB 56 million (including) and not exceed RMB 112 million (including). The specific number of repurchased shares and the amount will be subject to the actual number and amount of shares repurchased upon completion of the repurchase period. The repurchase period is not more than 12 months from the date the board approves this repurchase plan. For details, please refer to the Company’s announcement on March 14, 2026, in the “China Securities Journal,” “Securities Times,” “Securities Daily,” “Shanghai Securities Journal,” and the Giant Tide Information Network.

Situation of Obtaining Commitment Letter for Special Loan for Stock Repurchase from Financial Institutions

Recently, the Company obtained the “Commitment Letter for Stock Repurchase/Increase Loan” issued by the Qingdao Branch of China Everbright Bank Co., Ltd. (hereinafter referred to as “Everbright Bank Qingdao Branch”), committing to provide support for the Company’s special loan financing for this stock repurchase. The main content is as follows:

Lending Bank: Everbright Bank Qingdao Branch;
Loan Amount: Not exceeding RMB 100 million;
Loan Term: One year, extendable as needed;
Loan Purpose: Specifically for repurchasing the Company’s shares.
Other Matters

The actual amount of the special loan used for repurchase and the amount of self-raised funds used for the repurchase will not exceed the upper limit of the repurchase amount. The commitment letter obtained from the financial institution for the stock repurchase does not represent the Company’s commitment to the repurchase amount of this stock repurchase plan. The specific amount of funds for repurchased shares, the number of repurchased shares, etc., will be subject to the actual repurchase situation upon expiration of the repurchase period or completion of the share repurchase.

The Company will strictly follow the “Rules for Share Repurchase by Listed Companies,” “Self-Regulatory Guidelines No. 9 for Listed Companies on the Shenzhen Stock Exchange - Share Repurchase,” and other relevant regulations, and will make repurchase decisions based on market conditions within the repurchase period and implement them accordingly. At the same time, the Company will timely fulfill its information disclosure obligations based on the progress of the stock repurchase matters. Investors are advised to pay attention to investment risks.

Documents for Reference
“Commitment Letter for Stock Repurchase/Increase Loan from China Everbright Bank”

This announcement is hereby made.

Qingdao Yingpais Health Technology Co., Ltd.

Board of Directors

March 26, 2026

Stock Code: 002899 Stock Abbreviation: Yingpais Announcement No.: 2026-011

Qingdao Yingpais Health Technology Co., Ltd.

Announcement on Obtaining Commitment Letter for Special Loan for Stock Repurchase from Financial Institutions

Massive information and accurate interpretation, all in the Sina Finance APP.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes